FDA Inspection 1281734 — Danny Rischin, MBBS, FRACP, MD
The FDA completed an inspection of Danny Rischin, MBBS, FRACP, MD on August 22, 2025 in Melbourne. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 22, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Melbourne (Australia)
Additional Details
Clinical Investigator (CI)